Genentech Company Updates | Glassdoor.ca

Company Updates

  • We were recently recognized by the GreenBiz Group as one of the top 25 most sustainable fleet leaders! We've been setting ambitious sustainability goals for our business for the past 15 years and apply the same science-based approach to environmental sustainability as we do to making innovative medicines. Read more about our electrification program by following the link below.

  • We're focused on creating an environment where every employee feels valued, included, and able to contribute their best for the patients we serve. Quita Highsmith, our VP and Chief Diversity Officer, discussed our D&I strategy with Glassdoor and shares how we're driving better outcomes for our people, patients, business, and communities by advancing and boldly championing diversity, equity, and inclusion. Read more below.

  • Our Pharma Technical Operations team turns cells into the final medicine that is delivered to patients, managing all aspects of manufacturing and supply, including quality, engineering and supply chain. Thank you to the National Association of Manufacturers (NAM) Leadership Council for recognizing us with three Manufacturing Leadership Awards for excellence in sustainability, community service and talent management. Learn more about how we make and deliver medicines.

  • Embracing D&I within and beyond our company drives innovation across our business, improves scientific and clinical outcomes, and helps contribute to equitable healthcare access. We were recently featured on Glassdoor for our broad approach to D&I and as a company hiring now. See the article below.

  • COVID-19

    The last several months have been a stressful and confusing time for our patients impacted by the COVID-19 pandemic. Our Access Solutions team has risen to the challenge ? extending operating hours, considering the access implications of travel restrictions, helping patients make fewer trips to the pharmacy, and simplifying online and mobile processes. Learn more from Claire Scott, Vice President of Access Solutions, about how we?re adapting and evolving in response to the pandemic.

  • We're excited to welcome Aviv Regev, Ph.D., our new head of Research and Early Development, whose research on single-cell genomics paved the way for understanding disease on a cellular level. Learn more about our scientists and their groundbreaking research.

  • We're investing in technology today that will transform personalized healthcare in the future. Dr. Mark Lee, our Global Head of Personalized Healthcare Product Development, recently shared with POLITICO how Genentech is leveraging data to deliver a new era of personalized healthcare. Learn how we're working to deliver this next generation of the best possible care for patients.

  • COVID-19

    COVID-19 has necessitated new ways of working to ensure that the important work of discovering and delivering critical medicines continues despite the new complexities. Nancy Oaks, Head of Customer Engagement, and Jamie Freedman, Head of U.S. Medical Affairs share how our teams have adapted their ways of working, leveraged our new customer engagement model, and found innovative ways to deliver on our mission during the pandemic.

  • We strive to improve the health and wellbeing of all patients, and create a future of science that is more diverse, inclusive and equitable. We're announcing two new charitable funding opportunities. The two funds will focus on forging partnerships that tackle systemic inequalities across healthcare and education: (1) The Health Equity Innovations Fund will support efforts that address healthcare disparities for historically underserved communities, with a focus on advancing inclusive research and promoting equity in care. (2) The Diverse Future of STEM Fund will solicit grant proposals to help increase racial and ethnic diversity in the healthcare and biomedical research community through K-12, undergraduate and post-secondary learning opportunities. Learn more about our grantmaking programs and applying for funding below.

  • With all of our interns onboard for the summer, we?re thrilled to see the meaningful projects they'll work on! To spark up some fun, we kicked off a House Cup as a means for our interns to interact and foster a sense of community throughout the summer. Last month, a secret message revealed our house teams. Best of luck on your friendly challenges Genentech Interns! Learn more about our university and early career programs here.

Work at Genentech? Share Your Experiences

Genentech
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or